| pubmed-article:12584227 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12584227 | lifeskim:mentions | umls-concept:C0019163 | lld:lifeskim |
| pubmed-article:12584227 | lifeskim:mentions | umls-concept:C0369332 | lld:lifeskim |
| pubmed-article:12584227 | lifeskim:mentions | umls-concept:C0080103 | lld:lifeskim |
| pubmed-article:12584227 | lifeskim:mentions | umls-concept:C0001899 | lld:lifeskim |
| pubmed-article:12584227 | lifeskim:mentions | umls-concept:C0019167 | lld:lifeskim |
| pubmed-article:12584227 | lifeskim:mentions | umls-concept:C0524909 | lld:lifeskim |
| pubmed-article:12584227 | lifeskim:mentions | umls-concept:C0280274 | lld:lifeskim |
| pubmed-article:12584227 | lifeskim:mentions | umls-concept:C1550147 | lld:lifeskim |
| pubmed-article:12584227 | lifeskim:mentions | umls-concept:C0814259 | lld:lifeskim |
| pubmed-article:12584227 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:12584227 | pubmed:dateCreated | 2003-2-13 | lld:pubmed |
| pubmed-article:12584227 | pubmed:abstractText | Background and aims: Interferon (IFN) induced hepatitis B e antigen (HBeAg) seroconversion is durable in 80-90% of chronic hepatitis B patients. Preliminary reports on the durability of HBeAg seroconversion following lamivudine are contradictory. We investigated the durability of response following IFN, lamivudine, or IFN-lamivudine combination therapy in a meta-analysis of individual patient data. | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12584227 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:12584227 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12584227 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12584227 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:12584227 | pubmed:issn | 0017-5749 | lld:pubmed |
| pubmed-article:12584227 | pubmed:author | pubmed-author:HeathcoteJJ | lld:pubmed |
| pubmed-article:12584227 | pubmed:author | pubmed-author:SchalmS WSW | lld:pubmed |
| pubmed-article:12584227 | pubmed:author | pubmed-author:FontaineHH | lld:pubmed |
| pubmed-article:12584227 | pubmed:author | pubmed-author:ChemelloLL | lld:pubmed |
| pubmed-article:12584227 | pubmed:author | pubmed-author:de ManR ARA | lld:pubmed |
| pubmed-article:12584227 | pubmed:author | pubmed-author:LöhrH FHF | lld:pubmed |
| pubmed-article:12584227 | pubmed:author | pubmed-author:HanselB CBC | lld:pubmed |
| pubmed-article:12584227 | pubmed:author | pubmed-author:SuhD JDJ | lld:pubmed |
| pubmed-article:12584227 | pubmed:author | pubmed-author:SongB CBC | lld:pubmed |
| pubmed-article:12584227 | pubmed:author | pubmed-author:van NunenA... | lld:pubmed |
| pubmed-article:12584227 | pubmed:author | pubmed-author:JanssenH L... | lld:pubmed |
| pubmed-article:12584227 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12584227 | pubmed:volume | 52 | lld:pubmed |
| pubmed-article:12584227 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12584227 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12584227 | pubmed:pagination | 420-4 | lld:pubmed |
| pubmed-article:12584227 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:12584227 | pubmed:meshHeading | pubmed-meshheading:12584227... | lld:pubmed |
| pubmed-article:12584227 | pubmed:meshHeading | pubmed-meshheading:12584227... | lld:pubmed |
| pubmed-article:12584227 | pubmed:meshHeading | pubmed-meshheading:12584227... | lld:pubmed |
| pubmed-article:12584227 | pubmed:meshHeading | pubmed-meshheading:12584227... | lld:pubmed |
| pubmed-article:12584227 | pubmed:meshHeading | pubmed-meshheading:12584227... | lld:pubmed |
| pubmed-article:12584227 | pubmed:meshHeading | pubmed-meshheading:12584227... | lld:pubmed |
| pubmed-article:12584227 | pubmed:meshHeading | pubmed-meshheading:12584227... | lld:pubmed |
| pubmed-article:12584227 | pubmed:meshHeading | pubmed-meshheading:12584227... | lld:pubmed |
| pubmed-article:12584227 | pubmed:meshHeading | pubmed-meshheading:12584227... | lld:pubmed |
| pubmed-article:12584227 | pubmed:meshHeading | pubmed-meshheading:12584227... | lld:pubmed |
| pubmed-article:12584227 | pubmed:meshHeading | pubmed-meshheading:12584227... | lld:pubmed |
| pubmed-article:12584227 | pubmed:meshHeading | pubmed-meshheading:12584227... | lld:pubmed |
| pubmed-article:12584227 | pubmed:meshHeading | pubmed-meshheading:12584227... | lld:pubmed |
| pubmed-article:12584227 | pubmed:meshHeading | pubmed-meshheading:12584227... | lld:pubmed |
| pubmed-article:12584227 | pubmed:meshHeading | pubmed-meshheading:12584227... | lld:pubmed |
| pubmed-article:12584227 | pubmed:meshHeading | pubmed-meshheading:12584227... | lld:pubmed |
| pubmed-article:12584227 | pubmed:meshHeading | pubmed-meshheading:12584227... | lld:pubmed |
| pubmed-article:12584227 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12584227 | pubmed:articleTitle | Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase. | lld:pubmed |
| pubmed-article:12584227 | pubmed:affiliation | Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Centre Rotterdam, the Netherlands. | lld:pubmed |
| pubmed-article:12584227 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12584227 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:12584227 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:12584227 | pubmed:publicationType | Meta-Analysis | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12584227 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12584227 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12584227 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12584227 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12584227 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12584227 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12584227 | lld:pubmed |
